<DOC>
	<DOCNO>NCT03068767</DOCNO>
	<brief_summary>300 HBV carrier inadequate serum vitamin D level randomize two group : one supply vitamin D another without control . The marker HBV replication compare treatment .</brief_summary>
	<brief_title>The Relationship Between Vitamin D Hepatitis B Virus Replication</brief_title>
	<detailed_description>This randomize case-control trial . A total 300 HBV carrier inadequate vitamin D ( &lt; 30 ng/mL ) level enrol . They randomly divide two group : one group receive vitamin D supplement ( 2000 IU/day ) 2 month another group control . The serum vitamin D , HBV DNA qHBsAg level measure baseline vitamin D supplement . Whether HBV DNA qHBsAg significant change vitamin D supplement determine .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>&gt; 20 y/o , HBV carrier serum vitamin D &lt; 30ng/ml Other know cause hepatitis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HBV DNA , qHBsAg</keyword>
</DOC>